Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Beats Revenue Estimates

Relay Therapeutics, Inc. (RLAY) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.49. This compares to a loss of $0.69 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +16.33%. A quarter ago, it was expected that this company would post a loss of $0.5 per share when it actually produced a loss of $0.46, delivering a surprise of +8%. Over the last four quarters, the company ha ...